Navigation Links
Access MediQuip Announces Release of the Country's First Centralized Recall Management Service(SM) for Implantable Devices
Date:3/17/2010

LAKE MARY, Fla., March 17 /PRNewswire/ -- Access MediQuip, LLC, the nation's first and largest provider of outsourced implantable medical device management solutions to the healthcare industry, announced today it has enhanced its proprietary Recall Management Service, "RMS," for its customers nationwide. The new release is designed to protect patients, inform and empower surgeons and facilities, and help payers improve quality while managing cost.

"Access MediQuip has a long history of offering a wide array of solutions to those in the implantable medical device field," said Access MediQuip Chief Executive Officer Tim Hargarten. "With the release of RMS we are now able to provide benefits that extend beyond traditional cost management into the realms of quality and patient safety."

RMS leverages its expansive database of facility, device, and case related information to identify potentially affected patients through a series of reactive and proactive processes. This capability allows RMS to recognize patients who have already received a defective device, as well as those currently scheduled to receive one. These safeguards help payers realize substantial savings by avoiding unnecessary procedural costs and enabling providers to deliver higher quality patient care.

"One of the greatest challenges we face during a medical device recall event is the lack of readily available information," said Dr. Fabian D'Souza, founding President of Boston Strategic Partners Inc. "The process of pulling procedural records and correlating them to specific implanted devices, with various serial and lot numbers, is both costly and highly inefficient. RMS has streamlined this process by providing notifications of which patients were potentially affected and their corresponding case information."

About Access MediQuip

Access MediQuip was founded in 1997 and is the nation's first and largest provider of outsourced implantable medical device management solutions. The company works with thousands of payers, manufacturers and providers to manage the acquisition, financing, delivery and reimbursement of implantable medical devices such as orthopedic and spinal implants. The company is headquartered in Lake Mary, Florida. For more information, please visit www.accessmediquip.com.

SOURCE Access MediQuip, LLC

Back to top

RELATED LINKS
http://www.accessmediquip.com

'/>"/>

SOURCE Access MediQuip, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
11. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Actinic Keratosis Market ... to their offering.       (Logo: ... Keratosis Market and Competitive Landscape Highlights 2016, ... products, Actinic Keratosis epidemiology, Actinic Keratosis market ...
(Date:5/3/2016)... Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling capabilities and increase market presence. ... ... ... ... Sino-German High-Tech Fund ...
(Date:5/3/2016)... Ore. , May 3, 2016   BIOTRONIK ... importance of extending care beyond the implant at the ... May 4-7 in San Francisco . ... continually delivering the highest quality of patient care and ... are cared for each and every tomorrow," said ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 04, 2016 , ... The RIDER ... and development of DRACO broad-spectrum antiviral therapeutics. DRACOs have proven effective against all ... May 3, 2016 at http://igg.me/at/EndTheVirus and runs for 60 days, we ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... Nike Rugby ... junior rugby in San Diego. Willis, founder of Elite Rugby Camps and current Nike ... and players every year since 2009. , “I’m excited for our eighth summer ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... a master charity program created to assist the people of their local community. ... with nonprofit organizations and community leaders. Their hope is to bring awareness to ...
(Date:5/4/2016)... ... May 04, 2016 , ... Dr. Elyson and Dr. Assili, ... surgery at their office. Wisdom tooth removal, a common dental procedure, is performed for ... often are improperly erupted, resulting in risks of complications. By providing wisdom tooth removal ...
(Date:5/4/2016)... ... ... Francesca Loparco, Co-Founder of Queen City Dream Cars, an exotic car rental business ... at Christenbury Eye Center. The entrepreneur struggled with her computer, riding horses and driving ... her in-office consultation and eye exam. Francesca’s eyesight was restored to 20/20 in both ...
Breaking Medicine News(10 mins):